QA: BIODELIVERY SCIENCES INTERNATIONAL INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001103021_2022_BIODELIVERY_SCIENCES_INTERNATIONAL_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001103021, BIODELIVERY SCIENCES INTERNATIONAL INC

  xvar xval
0 AssetsCurrent 202,065,000
1 IntangibleAssetsNetIncludingGoodwill 2,715,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 119,816,000
4 LiabilitiesCurrent 82,378,000
5 LiabilitiesNoncurrent 219,000
6 remainder_Liabilities 54,177,000
7 CostOfGoodsAndServicesSold 23,373,000
8 SellingGeneralAndAdministrativeExpense 106,206,000
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses -55,238,000
11 remainder_Revenues 166,703,000
12 remainder_NetIncome -7,502,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 324,596,000
1 Liabilities 136,774,000
2 Expenses 74,341,000
3 Revenues 166,703,000
4 StockholdersEquity 187,822,000
5 NetIncome 84,860,000
6 ComprehensiveNetIncome 84,860,000
7 BaseVar 354,958,000
8 EconomicCapitalRatio 1.77

Edgar->Model Mapping

Feature Distribution

Change over Time